Review: The Leukemia & Lymphoma SocietyCancer Websites, Research Funding — By nygal on March 22, 2011 at 5:56 am
LLS’s mission is to cure blood cancers including leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Since the first funding in 1954, LLS has awarded more than $600 million in research funding.
This site highlights just some of the innovations that have made a difference in the lives of thousands of patients and their families and that will help achieve the ultimate goal – cures for blood cancer.
In 2009, The Leukemia & Lymphoma Society (LLS) celebrates its 60th anniversary and its commitment to curing blood cancers and helping patients and their families.
According to research, all companies and organizations, in order to survive and thrive in this world, must possess the following competencies: customer service, operational skill and an ability to innovate.
But only one of those competencies is what drives an organization. Looking at the big picture and determining the single characteristic that shines through everything they do — services for patients, research programs, advocacy work and revenue-generation programs — what quickly becomes apparent is that LLS is — above all else — innovative.
This trait shows up everywhere in their 60 years of existence.
Innovation is what has made LLS the successful organization it is today. It is responsible for their tremendous growth and the great strides in patient treatments and support they have provided.
Visit: The Leukemia & Lymphoma Society and share your comments and opinions below with the CancerDirectory.com community.